Quantitative analysis showed that CAG25 treatment significantly reduced the nuclear MBNL1 aggregation seen in these DM1 myotubes from day 8 to day 10 (Fig. 4d and Supplementary Fig. S6c). The gene discussed is MBNL1; the disease is myotonic dystrophy type 1.